14M102: Immune Regulation of Pain: Fibromyalgia and Pain Associated with Autoimmune Disorders

Monday, November 14, 2022

9:00 AM – 9:45 AM Eastern Time

Location: Room 126

CE: 0.75

All of the relevant financial relationships listed for faculty have been mitigated.

Moderator(s)

LC

Leslie Crofford, MD

Vanderbilt University Medical Center
Melbourne, AR, United States

Disclosure(s): No financial relationships with ineligible companies to disclose

This session will provide attendees with an overview of the current options for the treatment of fibromyalgia and where the deficiencies lie. Recent discoveries in the mechanisms of neuroinflammation can lead to the development of future therapeutics for fibromyalgia and pain associated with autoimmune disorders.

Learning Objectives:

Evaluate the efficacy of current fibromyalgia therapies
Explore the potential role of the adaptive immune system in the generation of chronic widespread pain
Describe the potential benefits of immune-based therapies for pain management in patients with chronic inflammatory diseases

Presentations:

9:00 AM – 9:15 AM Eastern Time

Miles to Go: The Long, Ongoing Search for Effective Fibromyalgia Treatments
Speaker: Yvonne C. Lee, MD, MMSc – Northwestern University
9:15 AM – 9:30 AM Eastern Time

Antibody-Dependent Processes in the Generation of Widespread Pain
Speaker: Andreas Goebel, MD – University of Liverpool
9:30 AM – 9:45 AM Eastern Time

Q&A